Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT02990845 · TERMINATED
Trial details
- NCT number
- NCT02990845
- Sponsor
- National Taiwan University Hospital
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-15
- Primary completion
- 2022-08-16
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.